Horizon Flexible Income ETF (FLXN)

BATS: FLXN · Real-Time Price · USD
24.63
+0.03 (0.12%)
Jul 28, 2026, 10:14 AM EDT - Market open
Assets$50.04M
Expense Ratio0.82%
PE Ration/a
Shares Out2.02M
Dividend (ttm)$2.30
Dividend Yield9.32%
Ex-Dividend DateJul 27, 2026
Payout FrequencyMonthly
Payout Ration/a
Volume321
Open24.63
Previous Close24.60
Day's Range24.63 - 24.63
52-Week Low24.56
52-Week High26.09
Betan/a
Holdings6
Inception DateJul 2, 2025

About FLXN

Fund Home Page

The Horizon Flexible Income ETF (FLXN) is an exchange-traded fund that mostly invests in high yield fixed income. The fund is actively managed, investing in high-yield fixed-income securities and adjusting exposures based on market and economic trends through income-producing assets, tactical credit shifts, and put spread overlays. This approach aims to deliver current income and pursue total return with risk-aware credit exposure. FLXN was launched on Jul 2, 2025 and is issued by Horizon.

Asset Class Fixed Income
Category High Yield Bond
Stock Exchange BATS
Ticker Symbol FLXN
ETF Provider Horizon

Dividend History

Ex-DividendAmountPay Date
Jul 27, 2026$0.19996Jul 28, 2026
Jun 29, 2026$0.22376Jun 30, 2026
May 28, 2026$0.18979May 29, 2026
Apr 27, 2026$0.68284Apr 28, 2026
Feb 27, 2026$0.11494Mar 2, 2026
Dec 24, 2025$0.73928Dec 26, 2025
Full Dividend History

Performance

FLXN had a total return of 7.15% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.02%.

News

Horizon Continues to Build Its Lineup of Exchange Traded Funds with the Launch of Two New Active Fixed Income ETFs

CHARLOTTE, N.C.--(BUSINESS WIRE)--Horizon launches Core Bond ETF (BNDY) and Flexible Income ETF (FLXN), expanding goals-based lineup, tools for advisors to meet client objectives.

Other symbols: BNDY
1 year ago - Business Wire

Pacira Biosciences to Snap Up Flexion Therapeutics; Shares Pop

New Jersey-based pharmaceutical company Pacira Biosciences, Inc. (PCRX) has signed an agreement to acquire biopharmaceutical firm Flexion Therapeutics, Inc. (FLXN) for $8.50 per share in cash and one ...

5 years ago - TipRanks